[HTML][HTML] Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance

S Kwon, JS Hyeon, Y Jung, L Li, JN An… - Kidney Research and …, 2023 - ncbi.nlm.nih.gov
Background As a leading cause of chronic kidney disease, clinical demand for noninvasive
biomarkers of diabetic kidney disease (DKD) beyond proteinuria is increasing …

Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance

S Kwon, JS Hyeon, Y Jung, L Li… - Kidney research …, 2023 - pubmed.ncbi.nlm.nih.gov
Background As a leading cause of chronic kidney disease, clinical demand for noninvasive
biomarkers of diabetic kidney disease (DKD) beyond proteinuria is increasing …

Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance

SI Kwon, JS Hyeon, Y Jung, L Lilin… - Kidney Research …, 2023 - oldkmbase.medric.or.kr
Background: As a leading cause of chronic kidney disease, clinical demand for noninvasive
biomarkers of diabetic kidney disease (DKD) beyond proteinuria is increasing …

Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance

K Soie, JS HYEON, J Youngae, LI Lilin… - Kidney Research …, 2023 - pesquisa.bvsalud.org
As a leading cause of chronic kidney disease, clinical demand for noninvasive biomarkers of
diabetic kidney disease (DKD) beyond proteinuria is increasing. Metabolomics is a popular …

[HTML][HTML] Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance

S Kwon, JS Hyeon, Y Jung, L Li, JN An… - Kidney Research and …, 2023 - krcp-ksn.org
Background As a leading cause of chronic kidney disease, clinical demand for noninvasive
biomarkers of diabetic kidney disease (DKD) beyond proteinuria is increasing …

Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance.

S Kwon, JS Hyeon, Y Jung, L Li, JN An… - Kidney Research and …, 2023 - europepmc.org
Background As a leading cause of chronic kidney disease, clinical demand for noninvasive
biomarkers of diabetic kidney disease (DKD) beyond proteinuria is increasing …

Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance

S Kwon, Y Jung, JN An, SH Yang, DK Kim… - Kidney Research and …, 2023 - kiss.kstudy.com
Background: As a leading cause of chronic kidney disease, clinical demand for noninvasive
biomarkers of diabetic kidney disease (DKD) beyond proteinuria is increasing …

Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance

S Kwon, Y Jung, JN An, SH Yang, DK Kim… - Kidney Research and …, 2023 - papersearch.net
Background: As a leading cause of chronic kidney disease, clinical demand for noninvasive
biomarkers of diabetic kidney disease (DKD) beyond proteinuria is increasing …

[PDF][PDF] Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance

S Kwon, JS Hyeon, Y Jung, L Li, JN An, YC Kim… - 2023 - researchgate.net
Background: As a leading cause of chronic kidney disease, clinical demand for noninvasive
biomarkers of diabetic kidney disease (DKD) beyond proteinuria is increasing …

[HTML][HTML] Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance

S Kwon, JS Hyeon, Y Jung, L Li, JN An… - Kidney Research and …, 2023 - krcp-ksn.org
Background As a leading cause of chronic kidney disease, clinical demand for noninvasive
biomarkers of diabetic kidney disease (DKD) beyond proteinuria is increasing …